ArticleDrugs - real world outcomes2022

Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.